Literature DB >> 4374155

Drug and sociotherapy in the aftercare of schizophrenic patients. II. Two-year relapse rates.

G E Hogarty, S C Goldberg, N R Schooler, R F Ulrich.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4374155     DOI: 10.1001/archpsyc.1974.01760170005001

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


× No keyword cloud information.
  32 in total

1.  Soteria Berne: an innovative milieu therapeutic approach to acute schizophrenia based on the concept of affect-logic.

Authors:  Luc Ciompi; Holger Hoffmann
Journal:  World Psychiatry       Date:  2004-10       Impact factor: 49.548

2.  Development of clinical methods for utilization review in psychiatric day treatment.

Authors:  K G Terkelsen; R H McCarthy; R L Munich; B E Hurley
Journal:  J Ment Health Adm       Date:  1994

Review 3.  Supportive therapy for schizophrenia.

Authors:  Lucy A Buckley; Nicola Maayan; Karla Soares-Weiser; Clive E Adams
Journal:  Cochrane Database Syst Rev       Date:  2015-04-14

4.  Effects of Cognitive Enhancement Therapy on Employment Outcomes in Early Schizophrenia: Results From a Two-Year Randomized Trial.

Authors:  Shaun M Eack; Gerard E Hogarty; Deborah P Greenwald; Susan S Hogarty; Matcheri S Keshavan
Journal:  Res Soc Work Pract       Date:  2011-01-27

Review 5.  Psychosocial treatments to promote functional recovery in schizophrenia.

Authors:  Robert S Kern; Shirley M Glynn; William P Horan; Stephen R Marder
Journal:  Schizophr Bull       Date:  2009-01-27       Impact factor: 9.306

6.  Schizophrenia--time to commit to policy change.

Authors:  W Wolfgang Fleischhacker; Celso Arango; Paul Arteel; Thomas R E Barnes; William Carpenter; Ken Duckworth; Silvana Galderisi; Lisa Halpern; Martin Knapp; Stephen R Marder; Mary Moller; Norman Sartorius; Peter Woodruff
Journal:  Schizophr Bull       Date:  2014-04       Impact factor: 9.306

Review 7.  A systematic review of the Soteria paradigm for the treatment of people diagnosed with schizophrenia.

Authors:  Tim Calton; Michael Ferriter; Nick Huband; Helen Spandler
Journal:  Schizophr Bull       Date:  2007-06-14       Impact factor: 9.306

8.  Outcome and risks of ultra-long-term treatment with an oral neuroleptic drug. Relationship between perazine serum levels and clinical variables in schizophrenic outpatients.

Authors:  A Pietzcker; A Poppenberg; J Schley; B Müller-Oerlinghausen
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1981

Review 9.  Drug treatment of resistant schizophrenia. Limitations and recommendations.

Authors:  A E Farmer; A Blewett
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

Review 10.  Weighing the evidence for harm from long-term treatment with antipsychotic medications: A systematic review.

Authors:  Nancy Sohler; Ben G Adams; David M Barnes; Gregory H Cohen; Seth J Prins; Sharon Schwartz
Journal:  Am J Orthopsychiatry       Date:  2015-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.